Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P344: Non-adherence to medical therapy is associated with hospitalisations and the development of active disease in inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

M. Severs*1, H. H. Fidder1, M.-J. Mangen2, M. E. van der Valk1, M. van der Have1, A. A. van Bodegraven3, 4, C. H. M. Clemens5, G. Dijkstra6, J. M. Jansen7, D. J. de Jong8, N. Mahmmod9, P. C. van de Meeberg10, A. E. van der Meulen- de Jong11, M. Pierik12, C. Y. Ponsioen13, M. J. L. Romberg- Camps3, P. D. Siersema1, J. R. Vermeijden14, J. van der Woude15, P. N. Zuithoff16, B. Oldenburg1

1University Medical Centre Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands, 2University Medical Centre Utrecht, Julius Centre for Health Sciences and Primary Care, Utrecht, Netherlands, 3ORBIS medical Centre, Gastroenterology and Hepatology, Sittard, Netherlands, 4VU medical Centre, Gastroenterology and Hepatology, Amsterdam, Netherlands, 5Diaconessenhuis, Gastroenterology and Hepatology, Leiden, Netherlands, 6University Medical Centre Groningen, Gastroenterology and Hepatology, Groningen, Netherlands, 7Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, Netherlands, 8University Medical Centre St. Radboud, Gastroenterology and Hepatology, Nijmegen, Netherlands, 9Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands, 10Slingeland Hospital, Gastroenterology and Hepatology, Doetinchem, Netherlands, 11Leiden University Medical Centre, Gastroenterology and Hepatology, Leiden, Netherlands, 12University Medical Centre Maastricht, Gastroenterology and Hepatology, Maastricht, Netherlands, 13Academic Medical Centre Amsterdam, Gastroenterology and Hepatology, Amsterdam, Netherlands, 14Meander Medical Centre, Gastroenterology and Hepatology, Amersfoort, Netherlands, 15Erasmus Medical Centre, Gastroenterology and Hepatology, Rotterdam, Netherlands, 16University Medical Centre Utrecht, Julius Centre for Health Sciences and Primary Care, Utrecht, Netherlands

P345: The Great Continental Divide: use of anti-TNF therapy in paediatric inflammatory bowel disease is significantly different in North America compared with other parts of the world.ECCO '16 Amsterdam
Year: 2016
Authors:

P. Church1, J. Hyams2, F. Ruemmele3, L. de Ridder4, D. Turner5, A. Griffiths*1, o.b.o. the International Paediatric IBD Network (PIBDNet)6

1Hospital for Sick Children, University of Toronto, Department of Gastroenterology, Hepatology and Nutrition, Toronto, Canada, 2Connecticut Children’s Medical Centre, Hartford, United States, 3Hospital Necker Enfants Malades, Department of Paediatric Gastroenterology, Paris, France, 4Children’s Hospital Erasmus MC Sophia, Department of Paediatric Gastroenterology, Rotterdam, Netherlands, 5Shaare Zedek Medical Centre, Department of Paediatric Gastroenterology, Jerusalem, Israel, 6International Paediatric IBD Network (PIBDNet), Paris, France

P346: Soluble transferrin receptor and its relation to anaemia in inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

R. Dudkowiak*, K. Neubauer, E. Poniewierka

Wroclaw Medical University, Department of Gastroenterology and Hepatology, Wroclaw, Poland

P347: Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapyECCO '16 Amsterdam
Year: 2016
Authors:

L. Del Nero*1, G. Bodini2, E. Giannini2, J. Anjali3, V. Savarino1, E. Savarino4

1University of Genoa, Internal Medicine Department, Genoa, Italy, 2University of Genoa, Department of Gastroenterology and Internal Medicine, Genoa, Italy, 3Prometheus Laboratories, Department of Research and Development, San Diego, California, United States, 4University of Padua, Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, Padua, Italy

P348: Novel model of care: the effect of a combined inflammatory bowel disease and antenatal clinicECCO '16 Amsterdam
Year: 2016
Authors:

C. Selinger*1, N. Carey1, G. Ulivi2, L. Walker2, F. Shaik1, T. Glanville2

1St James University Hospital, Gastroenterology, Leeds, United Kingdom, 2St James University Hospital, Obstetrics, Leeds, United Kingdom

P349: The effects of smoking on thiopurine metabolismECCO '16 Amsterdam
Year: 2016
Authors:

B. Warner*1, E. Johnston1, S. Fong1, P. Blaker1, M. Arenas-Hernandez2, A. Marinaki2, J. Sanderson1

1Guy’s and St Thomas’ NHS Foundation Trust, Gastroenterology, London, United Kingdom, 2Guy’s and St Thomas’ NHS Foundation Trust, Purine Laboratory, Viapath, London, United Kingdom

P350: The use of concomitant immunomodulators with adalimumab therapy in paediatric Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

K. Benkov*1, G. Russell2, C. Samson3, S. Steiner4, E.C. King5, J. Pratt5, S. Eichner6, R.B. Colletti7, ImproveCareNow Network8

1Icahn School of Medicine at Mount Sinai, Division of Pediatric Gastroenterology, New York, New York, United States, 2Boston Children’s Hospital, Harvard School of Medicine, Boston, Massachusetts, United States, 3Washington University School of Medicine, Saint Louis, Missouri, United States, 4Riley Hospital for Children, Pediatric Gastroenterology, Hepatology and Nutrition, Indianapolis, Indiana, United States, 5Cincinnati Children’s Hospital Medical Centre, Division of Biostatistics and Epidemiology, Cincinnati, Ohio, United States, 6AbbVie, Chicago, Illinois, United States, 7University of Vermont Children’s Hospital, Burlington, Vermont, United States, 8ImproveCareNow, Burlington, Vermont, United States

P351: Faecal calprotectin correlates well with extent of active endoscopic inflammation in patients with ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

D. Chayut1, M. Kaplan2, Y. Chowers3, M. Waterman*3

1The Technion - Israel Institute of Technology, B. Rappaport Faculty of Medicine, Haifa, Israel, 2Rambam Health Care Campus, Department of Laboratory Medicine, Haifa, Israel, 3Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel

P352: Melanoma in a population-based Australian inflammatory bowel disease cohortECCO '16 Amsterdam
Year: 2016
Authors:

G. Hume*

University of Queensland, School of Medicine, Brisbane, Australia

P353: Endoscopy-based management within the first year after surgery decreases the risk of clinical and surgical postoperative recurrences in Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A.-L. Boucher1, B. Pereira2, S. Decousus3, M. Goutte1, 4, F. Goutorbe1, A. Dubois5, J. Gagnière5, C. Borderon6, J. Joubert3, D. Pezet5, M. Dapoigny1, P. Dechelotte3, G. Bommelaer1, 4, A. Buisson*1, 4

1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2DRCI, Biostatistics Unit, Clermont-Ferrand, France, 3University Hospital Estaing, Pathology Department, Clermont-Ferrand, France, 4UMR 1071 Inserm/Université d’Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the host, Clermont-Ferrand, France, 5CHU Estaing, Department of Digestive surgery, Clermont-Ferrand, France, 6University Hospital Estaing, Paediatrics Department, Clermont-Ferrand, France

P354: A prospective randomised study: 2 mg/kg/d of azathioprine is an appropriate dosage for Chinese patients with Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

Y. Zhang*, J. Xia, Q. Cao

Sir Runrun Shaw Hospital, Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China

P355: Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

D. Seah*1, 2, M. Choy1, 2, 3, A. Gorelik4, F. Macrae5, M. Sparrow6, W.R. Connell3, G. Moore7, D. Van Langenberg8, P. De Cruz1, 2

1Austin Health, Department of Gastroenterology, Melbourne, Australia, 2University of Melbourne, Department of Medicine, Melbourne, Australia, 3St Vincent’s Hospital, Department of Gastroenterology, Melbourne, Australia, 4Royal Melbourne Hospital, Melbourne EpiCentre, Melbourne, Australia, 5Royal Melbourne Hospital, Department of Gastroenterology, Melbourne, Australia, 6The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia, 7Monash Health, Department of Gastroenterology, Melbourne, Australia, 8Eastern Health, Department of Gastroenterology, Melbourne, Australia

P356: Efficacy and safety of certolizumab pegol in Crohn’s disease patients with loss of response or intolerance to previous anti-TNFECCO '16 Amsterdam
Year: 2016
Authors:

I. Ferrer Bradley*1, I. Marín2, N. Maroto1, M. Mora1, E. Hinojosa1, B. López2, L. Menchén2, J. Hinojosa1

1Hospital de Manises, Gastroenterology, Valencia, Spain, 2Hospital Gregorio Marañón, Gastroenterology, Madrid, Spain

P357: Do you think that complementary and alternative medicine use is frequent amongst inflammatory bowel disease patients: Forget it!—results from a comparative studyECCO '16 Amsterdam
Year: 2016
Authors:

M. Rutka*1, T. Ferenci2, F. Nagy1, Z. Szepes1, K. Farkas1, A. Bálint1, R. Bor1, A. Milassin1, Z. Lénárt1, T. Molnar1

1University of Szeged, First Department of Medicine, Szeged, Hungary, 2John von Neumann Faculty of Informatics of Óbuda University, Budapest, Hungary

P358: Six-year adalimumab efficacy in steroid-dependent Crohn’s disease patients: a prospective ‘real-life’ studyECCO '16 Amsterdam
Year: 2016
Authors:

S. Renna*1, M. Cappello2, R. Dimitri3, F. Mocciaro3, M. Mazza2, M. Giunta4, M. Mendolaro2, E. Orlando1, M. Affronti1, A. Craxì2, M. Cottone1, A. Orlando1

1”Villa Sofia-Cervello” Hospital, Division of Internal Medicine, Palermo, Italy, 2Palermo University, Department of Gastroenterology and Hepatology, Palermo, Italy, 3Arnas Civico Di Cristina Benfratelli Hospital, Gastroenterology and Endoscopy Unit, Palermo, Italy, 4”Villa Sofia-Cervello” Hospital, Division of Internal Medicine,, Palermo, Italy

P359: Correlation of simple laboratory tests with clinical disease activity scores in inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

O. Tayfur Yurekli, H. Koseoglu, M. Basaran, N.S. Buyukasik, a. Demirezer Bolat, F.E. Akin*, m. Tahtaci, e. Selvi, O. Ersoy

Ankara Ataturk Research and Education Hospital, Gastroenterology, Ankara, Turkey

P360: A randomised, assessor-blinded, multicentre trial comparing the efficacy, safety, and tolerability of a new tailored dosing regimen to day-before dosing regimen of colon cleansing agent used before colonoscopyECCO '16 Amsterdam
Year: 2016
Authors:

R. Kiesslich*1, C. Angelin2, K. Raymond2, W. Man A Hing3, J. Masure3, M. Stoltenberg2

1Helios Dr. Horst Schmidt Kliniken, Department of Internal Medicine II, Wiesbaden, Germany, 2Ferring Pharmaceuticals Kay Fiskers Plads 11, Copenhagen, Denmark, 3Ferring International Centre S.A, St Prex, Switzerland

P361: Adherence to faecal calprotectin test in patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

C. Maréchal*1, I. Gastin2, C. Baumann2, B. Dirrenberger1, J.-L. Gueant2, L. Peyrin-Biroulet1

1University hospital, Gastro-enterology, Vandoeuvre-les-Nancy, France, 2Inserm U954, Vandoeuvre-les-Nancy, France

P362: Anti-virus treatment against CMV in patients with ulcerative colitis by the PCR monitoring for mucosal CMV-DNAECCO '16 Amsterdam
Year: 2016
Authors:

M. Tanaka*, T. Takagi, Y. Toyokawa, Y. Hotta, K. Uchiyama, Y. Naito, Y. Itoh

Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of Molecular Gastroenterology and Hepatology, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 6028–566, Japan

P363: Efficacy and safety of golimumab in patients with ulcerative colitis: a prospective multicentre studyECCO '16 Amsterdam
Year: 2016
Authors:

D. Varvara1, G. Costantino2, A.C. Privitera3, B. Principi4, M. Cappello5, S. Mazzuoli6, P. Paiano7, A. Tursi8, P. Paese9, W. Fries10, A. Andriulli1, F. Bossa*1

1IRCCS Casa Sollievo della Sofferenza, Gastroenterology, San Giovanni Rotondo, Italy, 2University of Messina, Clinical and experimental Medicine, Messina, Italy, 3Ospedale Cannizzaro, Chirurgia, Catania, Italy, 4University of Bari, Gastroenterology, Bari, Italy, 5University of Palermo, Gastroenterology, Palermo, Italy, 6Ospedale San Nicola Pellegrino, Gastroenterology, Trani, Italy, 7Ospedale di poggiardo, Gastroenterology, Poggiardo, Italy, 8ASL BAT, Gastroenterology, Andria, Italy, 9Ospedale Annunziata, Gastroenterology, Cosenza, Italy, 10University of Messina, Clinical and Experimental Medicine, Messina, Italy